Description
Management of Advanced Prostate Cancer, 1st ed. 2018
Coordinator: Kim Choung Soo
Language: EnglishSubjects for Management of Advanced Prostate Cancer:
Publication date: 07-2018
Support: Print on demand
Support: Print on demand
Description
/li>Contents
/li>Biography
/li>Comment
/li>
This textbook summarizes the state of the art in the management of locally advanced and metastatic prostate cancer with the aim of providing the knowledge required for optimal treatment decision making in individual cases. Readers will find comprehensive coverage of the latest developments in surgery, radiotherapy, androgen deprivation therapy (ADT), chemotherapy, and immunotherapy. The role of the hormonal therapies abiraterone and enzalutamide and docetaxel-based chemotherapy in castration-resistant prostate cancer and hormone-sensitive metastatic disease is carefully evaluated. Among the other therapies discussed are LHRH agonists and antagonists, cabazitaxel, radium-223, and various novel agents still under clinical trials. The section on surgical approaches addresses, among other topics, the use of robot-assisted radical prostatectomy, pelvic lymphadenectomy, and the benefits of adjuvant and neoadjuvant therapy. The current role of external beam radiotherapy, alone or in combination with ADT and brachytherapy, for locally advanced disease is reviewed. Management of Advanced Prostate Cancer will be a valuable resource for practitioners at all levels of expertise.
Section 1. Surgery for advanced prostate cancer.- Section 2 Radiotherapy for advanced prostate cancer.- Section 3. Androgen deprivation therapy for advanced prostate cancer.- Section 4. Chemotherapy and immunotherapy and palliative care for advanced prostate cancer.
Choung Soo Kim, M.D., Professor, Department of Urology, Asan Medical Center, Asan Medical Center Ulsan University, Seoul, Republic of Korea.
Summarizes the state of the art in the management of locally advanced and metastatic prostate cancer
Evaluates the role of abiraterone and enzalutamide, docetaxel-based chemotherapy, and novel agents
Discusses surgical approaches and the role of adjuvant and neoadjuvant therapy
Examines current radiotherapy techniques
© 2024 LAVOISIER S.A.S.
These books may interest you
Primer on Prostate Cancer 52.74 €